SECTRAL Trademark

Trademark Overview

On Wednesday, January 14, 1976, a trademark application was filed for SECTRAL with the United States Patent and Trademark Office. The USPTO has given the SECTRAL trademark a serial number of 73074265. The federal status of this trademark filing is CANCELLED - SECTION 18 as of Thursday, September 9, 2021. This trademark is owned by RHONE-POULENC INDUSTRIES, SOCIETE ANONYME. The SECTRAL trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PRODUCTS FOR HUMAN USE AND SPECIFICALLY, MEDICATION FOR THE TREATMENT OF CARDIO-VASCULAR DISEASES

General Information

Serial Number73074265
Word MarkSECTRAL
Filing DateWednesday, January 14, 1976
Status713 - CANCELLED - SECTION 18
Status DateThursday, September 9, 2021
Registration Number1061086
Registration DateTuesday, March 15, 1977
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPHARMACEUTICAL PRODUCTS FOR HUMAN USE AND SPECIFICALLY, MEDICATION FOR THE TREATMENT OF CARDIO-VASCULAR DISEASES

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code3 - Sec. 18 - Entire Registration
Class Status DateThursday, September 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAVENTIS PHARMA S.A.
Party Type42 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressF-92160 Antony Cedex
FR
Party NameRHONE-POULENC RORER S.A.
Party Type41 - New Owner After Registration
Legal Entity Type03 - Corporation
Address92160 ANTONY
FR
Party NameRHONE-POULENC INDUSTRIES, SOCIETE ANONYME
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPARIS 75008
FR

Trademark Events

Event DateEvent Description
Thursday, September 9, 2021CANCELLED SECTION 18-TOTAL
Thursday, September 9, 2021CANCELLATION TERMINATED NO. 999999
Thursday, August 26, 2021CANCELLATION GRANTED NO. 999999
Thursday, February 11, 2021CANCELLATION INSTITUTED NO. 999999
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 19, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, June 19, 2017REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Monday, June 19, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, June 19, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 2, 2017TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 15, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, November 8, 2007CASE FILE IN TICRS
Thursday, April 5, 2007REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, April 5, 2007REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, April 2, 2007ASSIGNED TO PARALEGAL
Tuesday, March 6, 2007REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Tuesday, March 6, 2007TEAS SECTION 8 & 9 RECEIVED
Tuesday, August 16, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 8, 1997REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, March 17, 1997REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Friday, January 25, 1991REGISTERED - SEC. 15 ACKNOWLEDGED
Friday, January 4, 1991RESPONSE RECEIVED TO POST REG. ACTION
Friday, January 4, 1991RESPONSE RECEIVED TO POST REG. ACTION
Monday, December 31, 1990POST REGISTRATION ACTION MAILED - SEC. 15
Thursday, August 2, 1990REGISTERED - SEC. 15 AFFIDAVIT FILED
Tuesday, July 6, 1982REGISTERED - SEC. 8 (6-YR) ACCEPTED

Related Keywords

sectral cardio vascular diseases treatment medication products human specifically pharmaceutical